June 07, 2018
Rose
Stakeholders across healthcare are beginning to weigh the benefits and challenges digital therapeutics could bring to their businesses, and pharma is no exception. During an afternoon roundtable session held yesterday at BIO 2018 in Boston, a panel of digital medicine and pharmaceutical representatives discussed the impact that these novel medicines has had, and could have, on drugmakers, regulators, and those prescribing the medications.
from MobiHealthNews https://ift.tt/2HrewL3
June 07, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Siren launches smart sock for diabetes patients, announces $3.4M in funding- NIH-funded study to use Trak, a home fertility test for men
- Apple Health Records launches out of beta with 39 health systems
- Merck, National Sleep Foundation to launch new Fitbit-powered study
- Experts discuss future of healthcare innovation for industry, providers, patients
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment